Autopsy report · NCT06380907
A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis
Cause of deathFunding or business
“Sponsor decision”
Life of this trial
- Registered 1 year 6 months before it started.
- Ran for about 1 year 7 months before it stopped.
- 65 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Zai Lab (Hong Kong), Ltd.
- Sponsor type
- Industry
- Conditions
- Plaque Psoriasis
- Interventions
- ZL-1102 1% w/w gel BID for 16 weeks; ZL-1102 3% w/w gel BID for 16 weeks; ZL-1102 3% w/w gel QD for 16 weeks; Placebo ZL-1102 0% w/w gel BID for 16 weeks; Placebo ZL-1102 0% w/w gel QD for 16 weeks
- Participants
- 65
- Sites
- 10
- Countries
- Australia
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.